Update on the role of cannabinoid receptors after ischemic stroke. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3337695/?toolubmed
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?toolubmed
Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain (full – 2012) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0049789
Contribution of Hypothermia and CB(1) Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3397930/?toolubmed
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full – 2012) http/www.jneuroinflammation.com/content/9/1/49
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full – 2012) http/rstb.royalsocietypublishing.org/content/367/1607/3193.full
Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3527460/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Review article: The endocannabinoid system in normal and pathological brain ageing (full – 2012) http/rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington's Disease: Role of CB(1) and CB(2) Receptors. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3382456/
Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3334436/
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. (full – 2012) http/stroke.ahajournals.org/content/43/1/211.long
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22451318
CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22508047
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids (abst - 2012) http/www.ncbi.nlm.nih.gov/pubmed/22801993
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/20980074
Δ(9) -THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22236282
Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22594565
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22571976
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22903455
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22971837
Cannabinoid Receptor Subtypes 1 and 2 Mediate Long-Lasting Neuroprotection and Improve Motor Behaviour Deficits After Transient Focal Cerebral Ischemia. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23069763
WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23202804
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23202804
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22697514?dopt=Abstract
Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22426389
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)-tetrahydrocannabinol (THC): neuroprotection and ERK signaling. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22821081
Researchers study neuroprotective properties in cannabis (news – 2012) http/www.foxnews.com/health/2012/03/20/researchers-study-neuroprotective-properties-in-cannabis/
Cannabinoids May Help Prevent MDMA induced brain damage (news – 2012) http/www.examiner.com/article/cannabinoids-may-help-prevent-mdma-induced-brain-damage
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full – 2013) http/www.jneuroinflammation.com/content/10/1/20
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full – 2013) http/www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity (full – 2013) http/www.molecularbrain.com/content/6/1/42
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120. (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0077577
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia (full – 2013) http/onlinelibrary.wiley.com/doi/10.1111/jnc.12347/full
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full – 2013) http/www.jneuroinflammation.com/content/10/1/91
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3636589/
The Influence of Cannabinoids on Generic Traits of Neurodegeneration. (full – 2013) http/onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
Does the neuroprotective role of anandamide display diurnal variations? (link to PDF– 2013) http/www.mdpi.com/1422-0067/14/12/23341
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF - 2013) http/www.eurekaselect.com/107976/article
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease (link to PDF– 2013) http/www.eurekaselect.com/107977/article
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/22795792
Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats (abst – 2013) http/link.springer.com/article/10.1007/s11064-012-0927-6
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23296873
Neuroprotective effects of topical CB1 agonist WIN 55212-2 on Retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23454099
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23587650
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23813098
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23960212
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23981015
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24030360
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23880371
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial biogenesis in a cell culture model of Parkinson’s Disease (abst – 2013) http/jnnp.bmj.com/content/84/11/e2.58.abstract
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24148086
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24012796
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23893294
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β signalling. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24256257
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24288245
Low Doses of THC (Cannabis) Can Halt Brain Damage, Study Suggests (news – 2013) http/www.sciencedaily.com/releases/2013/05/130530132531.htm
Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury (news – 2013) http/www.sciencedaily.com/releases/2013/02/130221141140.htm
Chemicals in marijuana 'protect nervous system' against MS (news – 2013) http/www.medicalnewstoday.com/articles/267161.php
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?toolubmed
Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain (full – 2012) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0049789
Contribution of Hypothermia and CB(1) Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3397930/?toolubmed
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full – 2012) http/www.jneuroinflammation.com/content/9/1/49
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full – 2012) http/rstb.royalsocietypublishing.org/content/367/1607/3193.full
Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3527460/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Review article: The endocannabinoid system in normal and pathological brain ageing (full – 2012) http/rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington's Disease: Role of CB(1) and CB(2) Receptors. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3382456/
Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3334436/
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. (full – 2012) http/stroke.ahajournals.org/content/43/1/211.long
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22451318
CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22508047
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids (abst - 2012) http/www.ncbi.nlm.nih.gov/pubmed/22801993
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/20980074
Δ(9) -THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22236282
Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22594565
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22571976
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22903455
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22971837
Cannabinoid Receptor Subtypes 1 and 2 Mediate Long-Lasting Neuroprotection and Improve Motor Behaviour Deficits After Transient Focal Cerebral Ischemia. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23069763
WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23202804
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23202804
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22697514?dopt=Abstract
Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22426389
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)-tetrahydrocannabinol (THC): neuroprotection and ERK signaling. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22821081
Researchers study neuroprotective properties in cannabis (news – 2012) http/www.foxnews.com/health/2012/03/20/researchers-study-neuroprotective-properties-in-cannabis/
Cannabinoids May Help Prevent MDMA induced brain damage (news – 2012) http/www.examiner.com/article/cannabinoids-may-help-prevent-mdma-induced-brain-damage
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full – 2013) http/www.jneuroinflammation.com/content/10/1/20
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full – 2013) http/www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity (full – 2013) http/www.molecularbrain.com/content/6/1/42
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120. (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0077577
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia (full – 2013) http/onlinelibrary.wiley.com/doi/10.1111/jnc.12347/full
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full – 2013) http/www.jneuroinflammation.com/content/10/1/91
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3636589/
The Influence of Cannabinoids on Generic Traits of Neurodegeneration. (full – 2013) http/onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
Does the neuroprotective role of anandamide display diurnal variations? (link to PDF– 2013) http/www.mdpi.com/1422-0067/14/12/23341
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF - 2013) http/www.eurekaselect.com/107976/article
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease (link to PDF– 2013) http/www.eurekaselect.com/107977/article
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/22795792
Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats (abst – 2013) http/link.springer.com/article/10.1007/s11064-012-0927-6
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23296873
Neuroprotective effects of topical CB1 agonist WIN 55212-2 on Retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23454099
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23587650
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23813098
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23960212
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23981015
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24030360
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23880371
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial biogenesis in a cell culture model of Parkinson’s Disease (abst – 2013) http/jnnp.bmj.com/content/84/11/e2.58.abstract
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24148086
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24012796
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23893294
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β signalling. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24256257
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24288245
Low Doses of THC (Cannabis) Can Halt Brain Damage, Study Suggests (news – 2013) http/www.sciencedaily.com/releases/2013/05/130530132531.htm
Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury (news – 2013) http/www.sciencedaily.com/releases/2013/02/130221141140.htm
Chemicals in marijuana 'protect nervous system' against MS (news – 2013) http/www.medicalnewstoday.com/articles/267161.php